Search Results

Your search for Rakesh Chopra, MD; Kavita Yadav, BDS, MPH; and Ravi Mehrotra, MD, DPhil, FRCPath matches 2 pages

Showing 1 - 2

By Rakesh Chopra, MD; Kavita Yadav, BDS, MPH; Vivek Agarwala, MD, DM, DNB; and Ravi Mehrotra, MD, DPhil, FRCPath / July 10, 2021

Reflections on Evolution of Breast Cancer Care in India Over the Past 4 Decades

India has witnessed a major paradigm shift in the field of breast cancer and its management over the past 4 decades. The discipline of medical oncology has evolved exponentially over this period—a growth that few other scientific disciplines have experienced. Interventions at the individual,...

covid-19

By Rakesh Chopra, MD; Kavita Yadav, BDS, MPH; and Ravi Mehrotra, MD, DPhil, FRCPath / November 25, 2020

Impact of COVID-19 on Cancer Care in India

With the announcement of a complete nationwide lockdown on March 25, 2020, to prevent the spread of COVID-19, a lot of unprecedented events came into being in India. The National Health Mission reported a 69% reduction in measles, mumps, and rubella vaccination in children; a 21% reduction in...

Jul

Today In Oncology

Search Results

Your search for Rakesh Chopra, MD; Kavita Yadav, BDS, MPH; and Ravi Mehrotra, MD, DPhil, FRCPath matches 2 pages

Reflections on Evolution of Breast Cancer Care in India Over the Past 4 Decades

Impact of COVID-19 on Cancer Care in India

MRD-Guided Therapy With Ibrutinib-Venetoclax or Ibrutinib Alone in Chronic Lymphocytic Leukemia

Metformin in Metastatic Prostate Cancer

Teclistamab for High-Risk, Heavily Pretreated Multiple Myeloma Real-World Data

Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1-KMT2A Alterations

Dual Menin and KAT6A-7 Inhibition Improves Outcomes in NUP98-Rearranged Pediatric AML Models